Clinical Trial Update: SH T00186 in the Treatment of Primary Dysmenorrhea [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SH T00186 for primary dysmenorrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• SH T00186

Snippet

Sponsor: Bayer | Conditions: Primary Dysmenorrhea | Phase 3 | Status: COMPLETED